Sorafenib therapy in orthotopic liver transplant recipients with hepatocellular carcinoma beyond Milan criteria on explant

被引：1
|
作者：
Satapathy, S. K. [1 ]
Das, K. [2 ]
Kocak, M. [3 ]
Helmick, R. A. [1 ]
Eason, J. [1 ]
Nair, S. [1 ]
Vanatta, J. M. [1 ]
机构：
[1] Univ Tennessee, Ctr Hlth Sci, Methodist Univ Hosp, Transplant Inst,Surg, Memphis, TN 38163 USA
[2] Univ Tennessee, Ctr Hlth Sci, Gastroenterol, Memphis, TN 38163 USA
[3] Univ Tennessee, Ctr Hlth Sci, Prevent Med, Memphis, TN 38163 USA
来源：
JOURNAL OF HEPATOLOGY | 2017年 / 66卷 / 01期
关键词：
D O I：
10.1016/S0168-8278(17)31702-6
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
SAT-096
引用
收藏
页码：S628 / S628
页数：1
相关论文
共 50 条
  • [1] Outcome of Sorafenib Therapy in Recipients of Orthotopic Liver Transplant With Explants Revealing HCC Beyond Milan Criteria
    Vanatta, Jason
    Das, Kanak
    Eason, James
    Modanlou, Kian
    Yoo, Min
    Nair, Satheesh
    Campos, Luis
    Nezakatgoo, Nosratollah
    Puri, Vichin
    Dbouk, Nader
    Satapathy, Sanjaya
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15 : 95 - 95
  • [2] No apparent benefit of preemptive sorafenib therapy in liver transplant recipients with advanced hepatocellular carcinoma on explant
    Satapathy, Sanjaya K.
    Das, Kanak
    Kocak, Mehmet
    Helmick, Ryan A.
    Eason, James D.
    Nair, Satheesh P.
    Vanatta, Jason M.
    [J]. CLINICAL TRANSPLANTATION, 2018, 32 (05)
  • [3] Sorafenib for hepatocellular carcinoma patients beyond Milan criteria after orthotopic liver transplantation: a case control study
    Chieh-Lin Teng
    Wen-Li Hwang
    Yi-Ju Chen
    Kuang-Hsi Chang
    Shao-Bin Cheng
    [J]. World Journal of Surgical Oncology, 10
  • [4] Sorafenib for hepatocellular carcinoma patients beyond Milan criteria after orthotopic liver transplantation: a case control study
    Teng, Chieh-Lin
    Hwang, Wen-Li
    Chen, Yi-Ju
    Chang, Kuang-Hsi
    Cheng, Shao-Bin
    [J]. WORLD JOURNAL OF SURGICAL ONCOLOGY, 2012, 10
  • [5] International study on the outcome of locoregional therapy for liver transplant in hepatocellular carcinoma beyond Milan criteria
    Degroote, Helena
    Pinero, Federico
    Costentin, Charlotte
    Notarpaolo, Andrea
    Boin, Ilka F.
    Boudjema, Karim
    Baccaro, Cinzia
    Chagas, Aline Lopes
    Bachellier, Philippe
    Ettorre, Giuseppe Maria
    Poniachik, Jaime
    Muscari, Fabrice
    Di Benedetto, Fabrio
    Hoyos Duque, Sergio
    Salame, Ephrem
    Cillo, Umberto
    Gadano, Adrian
    Vanlemmens, Claire
    Fagiuoli, Stefano
    Rubinstein, Fernando
    Burra, Patrizia
    Cherqui, Daniel
    Silva, Marcelo
    Van Vlierberghe, Hans
    Duvoux, Christophe
    [J]. JHEP REPORTS, 2021, 3 (05)
  • [6] Hepatocellular Carcinoma Recurrence Among Liver Transplant Recipients Within the Milan Criteria
    Felga, G.
    Evangelista, A. S.
    Salvalaggio, P. R.
    Curvelo, L. A.
    Della Guardia, B.
    Almeida, M. D.
    Afonso, R. C.
    Ferraz-Neto, B. H.
    [J]. TRANSPLANTATION PROCEEDINGS, 2012, 44 (08) : 2459 - 2461
  • [7] Postoperative use of Sorafenib in liver transplantation patients of hepatocellular carcinoma beyond Milan criteria
    黄磊
    [J]. 外科研究与新技术, 2012, 21 (01) : 47 - 47
  • [8] Safe Withdrawal of Sorafenib as Adjuvant Therapy after Liver Transplantation for Hepatocellular Carcinoma beyond Milan Criteria.
    Chen, Yinghua
    Luo, Wenhui
    Ju, Weiqiang
    Zhu, Xiaoshun
    He, Xiaoshun
    [J]. LIVER TRANSPLANTATION, 2014, 20 : S182 - S182
  • [9] Hepatocellular carcinoma beyond Milan criteria: Management and transplant selection criteria
    Mohammed Elshamy
    Federico Aucejo
    KV Narayanan Menon
    Bijan Eghtesad
    [J]. World Journal of Hepatology, 2016, (21) : 874 - 880
  • [10] Liver transplantation for hepatocellular carcinoma: the Milan criteria and beyond
    Karaca, C.
    Farajov, R.
    Yilmaz, C.
    Iakobadze, Z.
    Kilic, K.
    Doganay, L.
    Kadioglu, E.
    Kul, G.
    Tosun, A.
    Kilic, M.
    [J]. TRANSPLANTATION, 2018, 102 : 189 - 189
12345